These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 9485194
1. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Jeremias I, Herr I, Boehler T, Debatin KM. Eur J Immunol; 1998 Jan; 28(1):143-52. PubMed ID: 9485194 [Abstract] [Full Text] [Related]
2. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
3. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Tijoe IM, Smith CA, Herzenberg LA, Herzenberg LA. J Exp Med; 1997 Oct 20; 186(8):1365-72. PubMed ID: 9334376 [Abstract] [Full Text] [Related]
4. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation. Wang R, Zhang L, Zhang X, Moreno J, Luo X, Tondravi M, Shi Y. J Immunol; 2001 Feb 01; 166(3):1983-90. PubMed ID: 11160247 [Abstract] [Full Text] [Related]
5. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. Mariani SM, Matiba B, Armandola EA, Krammer PH. J Cell Biol; 1997 Apr 07; 137(1):221-9. PubMed ID: 9105050 [Abstract] [Full Text] [Related]
6. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H. Cell Death Differ; 2004 Jul 07; 11 Suppl 1():S86-96. PubMed ID: 15105837 [Abstract] [Full Text] [Related]
7. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis. Velthuis JH, Rouschop KM, De Bont HJ, Mulder GJ, Nagelkerke JF. J Biol Chem; 2002 Jul 05; 277(27):24631-7. PubMed ID: 11980895 [Abstract] [Full Text] [Related]
8. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Mariani SM, Krammer PH. Eur J Immunol; 1998 Mar 05; 28(3):973-82. PubMed ID: 9541592 [Abstract] [Full Text] [Related]
9. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis. Seol DW, Li J, Seol MH, Park SY, Talanian RV, Billiar TR. Cancer Res; 2001 Feb 01; 61(3):1138-43. PubMed ID: 11221844 [Abstract] [Full Text] [Related]
10. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. J Immunol; 2001 Aug 01; 167(3):1347-52. PubMed ID: 11466352 [Abstract] [Full Text] [Related]
11. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells. Hermisson M, Weller M. Cell Death Differ; 2003 Sep 01; 10(9):1078-89. PubMed ID: 12934082 [Abstract] [Full Text] [Related]
12. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC. Blood; 1996 Jun 15; 87(12):4959-66. PubMed ID: 8652808 [Abstract] [Full Text] [Related]
13. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha. Herr I, Posovszky C, Di Marzio LD, Cifone MG, Boehler T, Debatin KM. Oncogene; 2000 Aug 31; 19(37):4255-62. PubMed ID: 10980599 [Abstract] [Full Text] [Related]
14. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Mariani SM, Krammer PH. Eur J Immunol; 1998 May 31; 28(5):1492-8. PubMed ID: 9603453 [Abstract] [Full Text] [Related]
15. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Chlichlia K, Peter ME, Rocha M, Scaffidi C, Bucur M, Krammer PH, Schirrmacher V, Umansky V. Blood; 1998 Jun 01; 91(11):4311-20. PubMed ID: 9596680 [Abstract] [Full Text] [Related]
16. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma. Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN, Harrington WJ. Oncogene; 2001 Oct 25; 20(48):7029-40. PubMed ID: 11704827 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775 [Abstract] [Full Text] [Related]
18. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Choi C, Kutsch O, Park J, Zhou T, Seol DW, Benveniste EN. Mol Cell Biol; 2002 Feb 01; 22(3):724-36. PubMed ID: 11784850 [Abstract] [Full Text] [Related]
19. Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis. Boehrer S, Nowak D, Puccetti E, Ruthardt M, Sattler N, Trepohl B, Schneider B, Hoelzer D, Mitrou PS, Chow KU. Leuk Res; 2006 May 01; 30(5):597-605. PubMed ID: 16513168 [Abstract] [Full Text] [Related]
20. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. Mori S, Murakami-Mori K, Nakamura S, Ashkenazi A, Bonavida B. J Immunol; 1999 May 01; 162(9):5616-23. PubMed ID: 10228045 [Abstract] [Full Text] [Related] Page: [Next] [New Search]